The Efficacy of Bevacizumab in Different Line Chemotherapy for Chinese Patients with Metastatic Colorectal Cancer

Objective: To evaluate the effect of bevacizumab in different lines for Chinese patients with metastatic colorectal cancer (mCRC). Methods: Patients of mCRC treated with bevacizumab or not at Sun Yat-sen University Cancer Center from 2007 to 2013 were recruited as study and control group. Endpoints...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Cancer
Egile Nagusiak: Yin, Chenxi, Ma, Gang, Rong, Yuming, Kong, Pengfei, Yang, Qiong, Jiang, Chang, Liao, Fangxin, Zhang, Bei, He, Wenzhuo, Xia, Liangping
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Ivyspring International Publisher 2016
Gaiak:
Research Paper
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5039375/
https://ncbi.nlm.nih.gov/pubmed/27698931
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.15802
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak